In October 2024, a team of Chinese researchers at Peking University reported that a 25-year-old woman who had lived with Type 1 diabetes since childhood stopped needing insulin injections within 75 days of receiving an experimental stem cell transplant ge
A Chinese stem‑cell transplant reportedly freed a young Type 1 diabetic from insulin in just 75 days.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
In October 2024 a team at Peking University reported that a 25‑year‑old woman with lifelong Type 1 diabetes stopped needing insulin injections within 75 days after receiving an experimental stem‑cell transplant. Coverage highlights the case as a sign of potential progress.
Rockdale Citizen and KGUN 9 note that a clinical trial is expanding, while Diabetes In Control discusses whether stem‑cell therapy could change care for the disease. The Spokesman‑Review features reader responses, and Space Daily repeats the original October 2024 report.
Future reporting will focus on whether additional participants achieve similar outcomes, how regulators respond, and what next‑phase trial data emerge, according to the outlets tracking the story.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 141d ago.
Quick answers
What outcome was reported for the patient in the Peking University study?
The patient reportedly stopped needing insulin injections within 75 days of the stem‑cell transplant.
Which media outlets are covering the potential of stem‑cell therapy for Type 1 diabetes?
Rockdale Citizen, KGUN 9, Diabetes In Control, The Spokesman‑Review and Space Daily are all publishing related coverage.
What is the next step mentioned in the coverage regarding the therapy?
Reports indicate that a clinical trial is expanding to include more participants.
Coverage (5)
- ASK THE DOCTORS: Type 1 Diabetes Clinical Trial Expanding Rockdale Citizen · 141d ago
- Type one diabetes trial shows promising results in islet cell transplants KGUN 9 · 141d ago
- Could Stem Cell Therapy Change Type 1 Diabetes Forever? Preparing for the Next Era of Care Diabetes In Control · 141d ago
- Ask the doctors: Readers respond The Spokesman-Review · 141d ago
- In October 2024, a team of Chinese researchers at Peking University reported that a 25-year-old woman who had lived with Type 1 diabetes since childhood stopped needing insulin injections within 75 days of receiving an experimental stem cell transplant ge Space Daily · 141d ago
Topics
Related trends
China Signals Its Intention to Land on Jupiter's Moon Callisto
China's Tianwen-4 mission signals an attempt to land on Jupiter's moon Callisto, marking a major step in deep-space exploration.
Taiwan may take a backseat when Xi and Trump meet for a third time at an APEC summit
Taiwan navigates a delicate diplomatic presence at the China-hosted APEC summit as Xi Jinping and Donald Trump prepare for their third meeting, with Taipei sending Acer founder Stan Shih as envoy.
EXCLUSIVE: Trump's China data center curb advances despite Amazon, Google, Meta lobbying
Trump administration advances China data center restrictions despite intense lobbying from Amazon, Google, Meta, and Microsoft over AI infrastructure impacts.
China and Canada expand tariff relief while Ottawa-Washington relations are strained
Canada and China expanded tariff relief on pork, seafood, steel and aluminum after Prime Minister Mark Carney met President Xi Jinping in Shenzhen, deepening trade ties while Ottawa's relations with Washington remain strained.
Trump arrives just as Southeast Asian summit is ending, but still looms over talks
President Trump arrived in Manila on November 17, 2026, to begin a three-day Asia trip that includes a Quad meeting, a trade statement with Thailand, and a planned visit to China for nuclear talks with Xi Jinping and Vladimir Putin.
Tracking China’s War of Words Against Japan
Recent reporting tracks an expanding campaign by China involving transnational repression and cognitive warfare targeting Japan.